Factors associated with quality of life in patients with severe asthma: the impact of pharmacotherapy

ABSTRACT OBJECTIVE: To identify, characterize, and quantify associations of various factors with quality of life (QoL) in patients with asthma, according to the pharmacotherapy employed. METHODS: This was a cross-sectional study involving 49 patients (≥ 18 years of age) with severe uncontrolled...

Full description

Bibliographic Details
Main Authors: Daiane Silva Souza, Lúcia de Araújo Costa Beisl Noblat, Pablo de Moura Santos
Format: Article
Language:English
Published: Sociedade Brasileira de Pneumologia e Tisiologia 2015-12-01
Series:Jornal Brasileiro de Pneumologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132015000600496&lng=en&tlng=en
_version_ 1818011485844013056
author Daiane Silva Souza
Lúcia de Araújo Costa Beisl Noblat
Pablo de Moura Santos
author_facet Daiane Silva Souza
Lúcia de Araújo Costa Beisl Noblat
Pablo de Moura Santos
author_sort Daiane Silva Souza
collection DOAJ
description ABSTRACT OBJECTIVE: To identify, characterize, and quantify associations of various factors with quality of life (QoL) in patients with asthma, according to the pharmacotherapy employed. METHODS: This was a cross-sectional study involving 49 patients (≥ 18 years of age) with severe uncontrolled or refractory asthma treated at a specialized outpatient clinic of the Brazilian Unified Health Care System, regularly using high doses of inhaled corticosteroids (ICs) or other medications, and presenting comorbidities. At a single time point, QoL was assessed with the Asthma Quality of Life Questionnaire (AQLQ). The overall AQLQ score and those of its domains were correlated with demographic variables (gender and age); Asthma Control Questionnaire score; pharmacotherapy (initial IC dose, inhaler devices, and polytherapy); and comorbidities. RESULTS: Better AQLQ scores were associated with asthma control-overall (OR = 0.38; 95% CI: 0.004-0.341; p < 0.001), "symptoms" domain (OR = 0.086; 95% CI: 0.016-0.476; p = 0.001), and "emotional function" domain (OR = 0.086; 95% CI: 0.016-0.476; p = 0.001)-and with IC dose ≤ 800 µg-"activity limitation" domain (OR = 0.249; 95% CI: 0.070-0.885; p = 0.029). Worse AQLQ scores were associated with polytherapy-"activity limitation" domain (OR = 3.651; 95% CI: 1.061-12.561; p = 0.036)-and number of comorbidities ≤ 5-"environmental stimuli" domain (OR = 5.042; 95% CI: 1.316-19.317; p = 0.015). CONCLUSIONS: Our results, the importance of this issue, and the lack of studies taking pharmacotherapy into consideration warrant longitudinal studies to establish a causal relationship between the identified factors and QoL in asthma patients.
first_indexed 2024-04-14T06:08:29Z
format Article
id doaj.art-548c4ff0d26c4f3ab3e6e8a18a40fdff
institution Directory Open Access Journal
issn 1806-3756
language English
last_indexed 2024-04-14T06:08:29Z
publishDate 2015-12-01
publisher Sociedade Brasileira de Pneumologia e Tisiologia
record_format Article
series Jornal Brasileiro de Pneumologia
spelling doaj.art-548c4ff0d26c4f3ab3e6e8a18a40fdff2022-12-22T02:08:26ZengSociedade Brasileira de Pneumologia e TisiologiaJornal Brasileiro de Pneumologia1806-37562015-12-0141649650110.1590/S1806-37562015000004545S1806-37132015000600496Factors associated with quality of life in patients with severe asthma: the impact of pharmacotherapyDaiane Silva SouzaLúcia de Araújo Costa Beisl NoblatPablo de Moura SantosABSTRACT OBJECTIVE: To identify, characterize, and quantify associations of various factors with quality of life (QoL) in patients with asthma, according to the pharmacotherapy employed. METHODS: This was a cross-sectional study involving 49 patients (≥ 18 years of age) with severe uncontrolled or refractory asthma treated at a specialized outpatient clinic of the Brazilian Unified Health Care System, regularly using high doses of inhaled corticosteroids (ICs) or other medications, and presenting comorbidities. At a single time point, QoL was assessed with the Asthma Quality of Life Questionnaire (AQLQ). The overall AQLQ score and those of its domains were correlated with demographic variables (gender and age); Asthma Control Questionnaire score; pharmacotherapy (initial IC dose, inhaler devices, and polytherapy); and comorbidities. RESULTS: Better AQLQ scores were associated with asthma control-overall (OR = 0.38; 95% CI: 0.004-0.341; p < 0.001), "symptoms" domain (OR = 0.086; 95% CI: 0.016-0.476; p = 0.001), and "emotional function" domain (OR = 0.086; 95% CI: 0.016-0.476; p = 0.001)-and with IC dose ≤ 800 µg-"activity limitation" domain (OR = 0.249; 95% CI: 0.070-0.885; p = 0.029). Worse AQLQ scores were associated with polytherapy-"activity limitation" domain (OR = 3.651; 95% CI: 1.061-12.561; p = 0.036)-and number of comorbidities ≤ 5-"environmental stimuli" domain (OR = 5.042; 95% CI: 1.316-19.317; p = 0.015). CONCLUSIONS: Our results, the importance of this issue, and the lack of studies taking pharmacotherapy into consideration warrant longitudinal studies to establish a causal relationship between the identified factors and QoL in asthma patients.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132015000600496&lng=en&tlng=enAsmaAsma/quimioterapiaQualidade de VidaConduta do tratamento medicamentoso
spellingShingle Daiane Silva Souza
Lúcia de Araújo Costa Beisl Noblat
Pablo de Moura Santos
Factors associated with quality of life in patients with severe asthma: the impact of pharmacotherapy
Jornal Brasileiro de Pneumologia
Asma
Asma/quimioterapia
Qualidade de Vida
Conduta do tratamento medicamentoso
title Factors associated with quality of life in patients with severe asthma: the impact of pharmacotherapy
title_full Factors associated with quality of life in patients with severe asthma: the impact of pharmacotherapy
title_fullStr Factors associated with quality of life in patients with severe asthma: the impact of pharmacotherapy
title_full_unstemmed Factors associated with quality of life in patients with severe asthma: the impact of pharmacotherapy
title_short Factors associated with quality of life in patients with severe asthma: the impact of pharmacotherapy
title_sort factors associated with quality of life in patients with severe asthma the impact of pharmacotherapy
topic Asma
Asma/quimioterapia
Qualidade de Vida
Conduta do tratamento medicamentoso
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132015000600496&lng=en&tlng=en
work_keys_str_mv AT daianesilvasouza factorsassociatedwithqualityoflifeinpatientswithsevereasthmatheimpactofpharmacotherapy
AT luciadearaujocostabeislnoblat factorsassociatedwithqualityoflifeinpatientswithsevereasthmatheimpactofpharmacotherapy
AT pablodemourasantos factorsassociatedwithqualityoflifeinpatientswithsevereasthmatheimpactofpharmacotherapy